Pliant Therapeutics Inc (NAS:PLRX)
$ 13.455 0.055 (0.41%) Market Cap: 811.68 Mil Enterprise Value: 380.63 Mil PE Ratio: 0 PB Ratio: 1.86 GF Score: 36/100

Pliant Therapeutics Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 19, 2023 / 07:45PM GMT
Release Date Price: $30.17 (+4.07%)
Joey Stringer
Needham & Company - Analyst

Good afternoon, everyone. Thank you for joining the 22nd Annual Needham Healthcare Conference. My name is Joey Stringer and I'm one of the biotech analysts at Needham & Company. It's my pleasure to introduce our next presenting company, Pliant Therapeutics. Joining us today from Pliant is CEO, Bernard Coulie; and CMO, Ãric Lefebvre.

(Operator Instructions) So with that, we'll go ahead and get started. Bernard and Ãric, thank you so much for joining us today.

Bernard Coulie
Pliant Therapeutics, Inc. - President & CEO

Thanks, Joey.

Ã;ric Lefebvre
Pliant Therapeutics, Inc. - Chief Medical Officer

Thank you for having us.

Questions & Answers

Joey Stringer;
Needham & Company - Analyst

We'll jump right into it. And now that you've disclosed the 12-week data up to the 320 mg dose, what's been the feedback in physicians in the [IND] as well as the IPF community?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot